GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aptabio Therapeutics Inc (XKRX:293780) » Definitions » Total Premiums Earned

Aptabio Therapeutics (XKRX:293780) Total Premiums Earned


View and export this data going back to 2019. Start your Free Trial

What is Aptabio Therapeutics Total Premiums Earned?

Total Premiums Earned only applies to insurance companies.


Aptabio Therapeutics Business Description

Traded in Other Exchanges
N/A
Address
13, Heungdeok 1-ro, Giheung-gu, Tower 504, Gyeonggi-do, Yongin-Si, KOR, 16954
Aptabio Therapeutics Inc is a South Korean pharmaceutical company involved in discovery and development of selective inhibitors of the NOX family of enzymes and aptamer-based anti-cancer drugs. The product portfolio of the company include Lipofector-Q, Plusfector, Lipofector-EXT, Lipofector-2000, Lipofector-EZ and Lipofector-pMAX.